Copyright
©2010 Baishideng.
World J Gastroenterol. Feb 21, 2010; 16(7): 868-874
Published online Feb 21, 2010. doi: 10.3748/wjg.v16.i7.868
Published online Feb 21, 2010. doi: 10.3748/wjg.v16.i7.868
Table 3 Details of surgical procedures and pathology
| Arm A (n = 32) | Arm B (n = 35) | |
| Complete resection R0 (%) | 29 (85) | 32 (91) |
| Non-radical resection (%) | 2 (5.8) | 2 (5.7) |
| No resection pM1 (peritoneum) (%) | 1 (2.9) | 1 (2.8) |
| pCR n (%) | 4 (11.7) | NA |
| pPR n (%) | 18 (55) | NA |
| Total gastrectomy | 20 | 24 |
| Subtotal gastrectomy | 11 | 10 |
| D-2 lymphadenectomy | 29 | 31 |
| D-3 lymphadenectomy | - | 2 |
| Excised lymph nodes median (range) | 20 (9-39) | 26 (13-76) |
| Metastatic lymph nodes median (range) | 1 (0-23) | 5 (0-50) |
- Citation: Biffi R, Fazio N, Luca F, Chiappa A, Andreoni B, Zampino MG, Roth A, Schuller JC, Fiori G, Orsi F, Bonomo G, Crosta C, Huber O. Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer. World J Gastroenterol 2010; 16(7): 868-874
- URL: https://www.wjgnet.com/1007-9327/full/v16/i7/868.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i7.868